Boston Scientific to Appeal $700 Million Verdict

Boston Scientific said it will appeal a $700 million verdict against it after a United States District Court judge in Delaware found that it had violated a Johnson & Johnson patent covering bare-metal stent technology. The suit, originally filed in 1997, concerned Boston Scientific's NIR stent, which it hasn't sold since 2004. Last month, the court denied Boston Scientific's motion for a new trial and approved J&J's motion for entry of judgment.

October 1, 2008

1 Min Read
Boston Scientific to Appeal $700 Million Verdict

The decision awarded J&J about $400 million in damages and about $300 million in interest.J&J also won $500 million from Medtronic for violating the same patent, bringing its haul to $1.2 billion. It can buy another company or two with that.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like